rxstat › Classes › Antimetabolites

Antimetabolites: shortage status in Canada

4 of the 10 antimetabolites rxstat tracks are currently in shortage in Canada. When one drug in a class is short, demand often shifts to its alternatives, so related drugs can tighten too; each page below shows which manufacturers are affected and the latest recovery estimates.
Partial shortageCapecitabine1 of 14 reported products affected · est. return Jun 26, 2026Partial shortageClofarabine1 of 1 reported products affected · est. return Jul 17, 2026Partial shortageMethotrexate3 of 31 reported products affected · est. return Jun 30, 2023Partial shortagePemetrexed4 of 12 reported products affectedNo current shortageAzacitidineNo current shortageCladribineNo current shortageCytarabineNo current shortageFludarabineNo current shortageFluorouracilNo current shortageMercaptopurine

Guides: what to do when your medication is in shortage · how to read these statuses

Class groupings follow the WHO ATC classification in Health Canada's reports. Data reflects manufacturer mandatory filings; see methodology.